Chattem Sanofi Drug Patent Portfolio

Chattem Sanofi owns 11 orange book drugs protected by 34 US patents with Xyzal Allergy 24Hr having the least patent protection, holding only 1 patent. And Children'S Allegra Hives with maximum patent protection, holding 19 patents. Given below is the list of Chattem Sanofi's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8933097 Fexofenadine suspension formulation 02 Aug, 2030
Active
US8633194 Pharmaceutical composition of piperazine derivatives 16 Oct, 2027
Active
US6723348 Orodispersible tablets containing fexofenadine 26 Nov, 2021 Expired
US8075911 Transparent transdermal nicotine delivery devices 22 May, 2021 Expired
US6613357 Osmotic device containing pseudoephedrine and an H1 antagonist 25 Dec, 2020 Expired
US8663680 Transparent transdermal nicotine delivery devices 13 Feb, 2020 Expired
US8999379 Transparent transdermal nicotine delivery devices 13 Feb, 2020 Expired
US9205059 Transparent transdermal nicotine delivery devices 15 Dec, 2019 Expired
US6039974 Pharmaceutical composition for combination of piperidinoalkanol-decongestant 31 Jul, 2018 Expired
USRE39069 Multi-layered osmotic device 29 May, 2018 Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017 Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017 Expired
US5976573 Aqueous-based pharmaceutical composition 03 Jul, 2016 Expired
US6143329 Aqueous-based pharmaceutical composition 03 Jul, 2016 Expired
US7977045 Aqueous-based pharmaceutical composition 03 Jul, 2016 Expired
US5738872 Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015 Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015 Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015 Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015 Expired
US5738872 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015 Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015 Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015 Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015 Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014 Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014 Expired
US5578610 Piperidine derivatives 26 May, 2014 Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014 Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014 Expired
US5698558 Methods for treating allergic disorders using optically pure (-) cetirizine 26 Jan, 2014 Expired
US5578610 Piperidine derivatives 26 Nov, 2013 Expired
US5698558 Methods for treating allergic disorders using optically pure (-) cetirizine 26 Jul, 2013 Expired
US5508038 Polyisobutylene adhesives for transdermal devices 16 Apr, 2013 Expired
US6187791 Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012 Expired
US6399632 Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Chattem Sanofi.

Activity Date Patent Number
Patent litigations
Expire Patent 15 Jan, 2024 US9205059
Expire Patent 15 Jan, 2024 US8075911
Maintenance Fee Reminder Mailed 31 Jul, 2023 US9205059
Maintenance Fee Reminder Mailed 31 Jul, 2023 US8075911
Expire Patent 15 May, 2023 US8999379
Maintenance Fee Reminder Mailed 28 Nov, 2022 US8999379
Payment of Maintenance Fee, 8th Year, Large Entity 13 Jul, 2022 US8933097
Payment of Maintenance Fee, 8th Year, Large Entity 13 Jul, 2022 US8933097
Expire Patent 11 Apr, 2022 US8663680
Maintenance Fee Reminder Mailed 25 Oct, 2021 US8663680
Review Certificate Mailed 16 Aug, 2021 US8633194
Review Certificate 22 Jul, 2021 US8633194
Payment of Maintenance Fee, 8th Year, Large Entity 07 Jul, 2021 US8633194
Termination or Final Written Decision 09 Jun, 2020 US8633194
Expire Patent 19 Aug, 2019 US7977045


Chattem Sanofi's Drug Patent Litigations

Chattem Sanofi's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 02, 1999, against patent number US6037353. The petitioner , challenged the validity of this patent, with YOUNG as the respondent. Click below to track the latest information on how companies are challenging Chattem Sanofi's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8633194 December, 2018 Final Written Decision
(09 Jun, 2020)
UCB Biopharma Sprl et al. Apotex Inc. et al.
US8075911 June, 2010 Decision
(25 May, 2011)
Robert M. Gale
US6037353 November, 1999 Decision
(02 Nov, 1999)
YOUNG


Chattem Sanofi Drug Patents' Oppositions Filed in EPO

Chattem Sanofi drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 23, 2010, by Zentiva K.S.. This opposition was filed on patent number EP05758582A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP05758582A Jun, 2010 Zentiva k.s. Revoked


Chattem Sanofi's Family Patents

Chattem Sanofi drugs have patent protection in a total of 40 countries. It's US patent count contributes only to 6.1% of its total global patent coverage. 12 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Chattem Sanofi Drug List

Given below is the complete list of Chattem Sanofi's drugs and the patents protecting them.


1. Allegra

Allegra is protected by 18 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US5738872
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5855912
(Pediatric)
Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5932247
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US6113942
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5738872 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US7135571
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra's drug page


2. Allegra Allergy

Allegra Allergy is protected by 16 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US5855912
(Pediatric)
Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5932247
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US6113942
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US7135571
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra Allergy's drug page


3. Allegra-d 12 Hour Allergy And Congestion

Allegra-d 12 Hour Allergy And Congestion is protected by 15 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6039974 Pharmaceutical composition for combination of piperidinoalkanol-decongestant 31 Jul, 2018
(6 years ago)
Expired
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US5855912
(Pediatric)
Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US6113942
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US7135571
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra-d 12 Hour Allergy And Congestion's drug page


4. Allegra-d 24 Hour Allergy And Congestion

Allegra-d 24 Hour Allergy And Congestion is protected by 10 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6613357 Osmotic device containing pseudoephedrine and an H1 antagonist 25 Dec, 2020
(3 years ago)
Expired
USRE39069 Multi-layered osmotic device 29 May, 2018
(6 years ago)
Expired
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra-d 24 Hour Allergy And Congestion's drug page


5. Allegra Hives

Allegra Hives is protected by 16 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US5855912
(Pediatric)
Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5932247
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US6113942
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US7135571
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra Hives's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Children's Allegra Allergy

Children's Allegra Allergy is protected by 19 patents, out of which 18 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8933097 Fexofenadine suspension formulation 02 Aug, 2030
(5 years from now)
Active
US6723348 Orodispersible tablets containing fexofenadine 26 Nov, 2021
(2 years ago)
Expired
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US5855912
(Pediatric)
Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5932247
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US6113942
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5738872 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US7135571
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Allegra Allergy's drug page


7. Children's Allegra Hives

Children's Allegra Hives is protected by 19 patents, out of which 18 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8933097 Fexofenadine suspension formulation 02 Aug, 2030
(5 years from now)
Active
US6723348 Orodispersible tablets containing fexofenadine 26 Nov, 2021
(2 years ago)
Expired
US6037353
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 14 Sep, 2017
(7 years ago)
Expired
US6037353 Method of providing an antihistaminic effect in a hepatically impaired patient 14 Mar, 2017
(7 years ago)
Expired
US5855912
(Pediatric)
Pharmaceutical compositions for piperidinalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5932247
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US6113942
(Pediatric)
Pharmaceutical composition for piperidinoalkanol compounds 28 Aug, 2015
(9 years ago)
Expired
US5738872 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5855912 Pharmaceutical compositions for piperidinalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US5932247 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US6113942 Pharmaceutical composition for piperidinoalkanol compounds 28 Feb, 2015
(9 years ago)
Expired
US7135571
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US7138524
(Pediatric)
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 Nov, 2014
(10 years ago)
Expired
US5578610
(Pediatric)
Piperidine derivatives 26 May, 2014
(10 years ago)
Expired
US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US7138524 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof 18 May, 2014
(10 years ago)
Expired
US5578610 Piperidine derivatives 26 Nov, 2013
(10 years ago)
Expired
US6187791
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired
US6399632
(Pediatric)
Method of providing an antihistaminic effect in a hepatically impaired patient 11 Nov, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Allegra Hives's drug page


8. Nasacort Allergy 24 Hour

Nasacort Allergy 24 Hour is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5976573 Aqueous-based pharmaceutical composition 03 Jul, 2016
(8 years ago)
Expired
US6143329 Aqueous-based pharmaceutical composition 03 Jul, 2016
(8 years ago)
Expired
US7977045 Aqueous-based pharmaceutical composition 03 Jul, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nasacort Allergy 24 Hour's drug page


9. Nicoderm Cq

Nicoderm Cq is protected by 5 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8075911 Transparent transdermal nicotine delivery devices 22 May, 2021
(3 years ago)
Expired
US8663680 Transparent transdermal nicotine delivery devices 13 Feb, 2020
(4 years ago)
Expired
US8999379 Transparent transdermal nicotine delivery devices 13 Feb, 2020
(4 years ago)
Expired
US9205059 Transparent transdermal nicotine delivery devices 15 Dec, 2019
(4 years ago)
Expired
US5508038 Polyisobutylene adhesives for transdermal devices 16 Apr, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nicoderm Cq's drug page


10. Xyzal

Xyzal is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5698558
(Pediatric)
Methods for treating allergic disorders using optically pure (-) cetirizine 26 Jan, 2014
(10 years ago)
Expired
US5698558 Methods for treating allergic disorders using optically pure (-) cetirizine 26 Jul, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyzal's drug page


11. Xyzal Allergy 24hr

Xyzal Allergy 24hr is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8633194 Pharmaceutical composition of piperazine derivatives 16 Oct, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyzal Allergy 24hr's drug page